US4503939A
(en)
*
|
1983-08-19 |
1985-03-12 |
Westinghouse Electric Corp. |
Elevator system
|
ATE547119T1
(de)
|
1997-03-21 |
2012-03-15 |
Chugai Pharmaceutical Co Ltd |
Präventives oder therapeutisches mittel mit einem il-6-antagonisten als wirkstoff für durch sensibilisierte t-zellen vermittelte erkrankungen
|
IT1291932B1
(it)
*
|
1997-06-20 |
1999-01-21 |
Angeletti P Ist Richerche Bio |
Composizioni farmaceutiche antitumorali capaci anche di ridurre la farmacoresistenza in cellule tumorali, in particolare di carcinoma
|
US20020187150A1
(en)
*
|
1997-08-15 |
2002-12-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient
|
DE19818044A1
(de)
*
|
1998-04-22 |
1999-10-28 |
Klinge Co Chem Pharm Fab |
Verwendung von Vitamin-PP-Verbindungen
|
US6468528B1
(en)
*
|
1999-02-01 |
2002-10-22 |
Amgen Canada Inc. |
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
|
UA80091C2
(en)
*
|
2001-04-02 |
2007-08-27 |
Chugai Pharmaceutical Co Ltd |
Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
|
ATE399561T1
(de)
|
2001-11-02 |
2008-07-15 |
Yoshiko Yasuda |
Verwendung von emp9 zur prävention von proliferativen organerkrankungen
|
IL161630A0
(en)
*
|
2001-11-06 |
2004-09-27 |
Applied Research Systems |
Methods of treating endometreosis
|
AU2002346369B2
(en)
|
2001-11-14 |
2009-08-27 |
Eusa Pharma (Uk) Ltd |
Anti-IL-6 antibodies, compositions, methods and uses
|
EP2338910B1
(de)
*
|
2002-01-18 |
2015-07-08 |
ZymoGenetics, Inc. |
Zytokinrezeptor Zyctor17-Multimere
|
WO2003068259A1
(en)
|
2002-02-14 |
2003-08-21 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing solution pharmaceuticals
|
AU2003235948A1
(en)
*
|
2002-04-25 |
2003-11-10 |
Chugai Seiyaku Kabushiki Kaisha |
Remedy for lung cancer
|
CA2506230A1
(en)
*
|
2002-11-15 |
2004-06-03 |
Centocor, Inc. |
Anti-angiogenic uses of il-6 antagonists
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
US20050100550A1
(en)
*
|
2003-11-10 |
2005-05-12 |
Mohit Trikha |
Anti-angiogenic uses of IL-6 antagonists
|
EP3736295A1
(de)
|
2004-03-24 |
2020-11-11 |
Chugai Seiyaku Kabushiki Kaisha |
Subtypen des humanisierten antikörpers gegen interleukin-6-rezeptor
|
US8017395B2
(en)
|
2004-12-17 |
2011-09-13 |
Lifescan, Inc. |
Seeding cells on porous supports
|
PE20061324A1
(es)
|
2005-04-29 |
2007-01-15 |
Centocor Inc |
Anticuerpos anti-il-6, composiciones, metodos y usos
|
EP2301969B1
(de)
|
2005-05-06 |
2015-12-23 |
ZymoGenetics, Inc. |
IL-31-monoklonale Antikörper und Verfahren zu deren Verwendung
|
PT1888123E
(pt)
|
2005-06-08 |
2013-03-13 |
Janssen Biotech Inc |
Uma terapêutica celular para a degeneração ocular
|
JP2007091710A
(ja)
*
|
2005-08-31 |
2007-04-12 |
Ishikawajima Harima Heavy Ind Co Ltd |
薬、薬の誘導装置、磁気検出装置及び薬の設計方法
|
WO2008001851A1
(en)
|
2006-06-28 |
2008-01-03 |
Ihi Corporation |
Drug, drug induction device, magnetic detector and method of designing drug
|
EP1966244B1
(de)
*
|
2005-12-30 |
2012-03-21 |
Merck Patent GmbH |
Die bindung von mit il-6ralpha komplexiertem il-6 an gp130 verhindernde anti-il-6-antikörper
|
US8741643B2
(en)
|
2006-04-28 |
2014-06-03 |
Lifescan, Inc. |
Differentiation of pluripotent stem cells to definitive endoderm lineage
|
US8080248B2
(en)
|
2006-06-02 |
2011-12-20 |
Regeneron Pharmaceuticals, Inc. |
Method of treating rheumatoid arthritis with an IL-6R antibody
|
ES2398076T3
(es)
|
2006-06-02 |
2013-03-13 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos de alta afinidad contra el receptor de IL-6 humano
|
MX2009001110A
(es)
*
|
2006-08-03 |
2009-05-11 |
Vaccinex Inc |
Anticuerpos monoclonales anti-il-6 y usos de los mismos.
|
US20080081041A1
(en)
*
|
2006-09-29 |
2008-04-03 |
Jeffrey Nemeth |
Method of Using IL6 Antagonists with Mitoxantrone for Prostate Cancer
|
US8178101B2
(en)
|
2007-05-21 |
2012-05-15 |
Alderbio Holdings Inc. |
Use of anti-IL-6 antibodies having specific binding properties to treat cachexia
|
US9701747B2
(en)
|
2007-05-21 |
2017-07-11 |
Alderbio Holdings Llc |
Method of improving patient survivability and quality of life by anti-IL-6 antibody administration
|
US20090238825A1
(en)
*
|
2007-05-21 |
2009-09-24 |
Kovacevich Brian R |
Novel rabbit antibody humanization methods and humanized rabbit antibodies
|
MX2009012493A
(es)
*
|
2007-05-21 |
2010-01-20 |
Alder Biopharmaceuticals Inc |
Metodos de humanizacion de anticuerpo de conejo novedosos y anticuerpos de conejo humanizados.
|
US8252286B2
(en)
*
|
2007-05-21 |
2012-08-28 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
US8062864B2
(en)
|
2007-05-21 |
2011-11-22 |
Alderbio Holdings Llc |
Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
|
NZ597767A
(en)
*
|
2007-05-21 |
2013-06-28 |
Bristol Myers Squibb Co |
Antibodies to IL-6 and use thereof
|
US7906117B2
(en)
*
|
2007-05-21 |
2011-03-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever
|
US8404235B2
(en)
|
2007-05-21 |
2013-03-26 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
US9080145B2
(en)
|
2007-07-01 |
2015-07-14 |
Lifescan Corporation |
Single pluripotent stem cell culture
|
CN101952415B
(zh)
|
2007-07-31 |
2017-06-27 |
生命扫描有限公司 |
人胚胎干细胞的分化
|
CN101246160B
(zh)
*
|
2007-09-06 |
2012-11-21 |
三峡大学 |
在体外用ELISA方法建立的IL-6/sIL-6R结合的分子模型
|
EP2196220B1
(de)
*
|
2007-10-02 |
2014-12-03 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibierende anti-IL-6 Rezeptor Antikörper für die Behandlung von Graft-versus-Host-Reaktion
|
CA2706560C
(en)
|
2007-11-27 |
2017-02-28 |
Lifescan, Inc. |
Differentiation of human embryonic stem cells to pancreatic cells
|
ES2660036T3
(es)
|
2007-12-07 |
2018-03-20 |
Zymogenetics, Inc. |
Moléculas de anticuerpo humanizadas específicas para IL-31
|
PE20091174A1
(es)
|
2007-12-27 |
2009-08-03 |
Chugai Pharmaceutical Co Ltd |
Formulacion liquida con contenido de alta concentracion de anticuerpo
|
US20090169484A1
(en)
|
2007-12-28 |
2009-07-02 |
Ihi Corporation |
Iron-salen complex
|
CN102046779A
(zh)
|
2008-02-21 |
2011-05-04 |
森托科尔奥索生物科技公司 |
用于细胞粘附、培养和分离的方法、表面改性培养板和组合物
|
US8623648B2
(en)
|
2008-04-24 |
2014-01-07 |
Janssen Biotech, Inc. |
Treatment of pluripotent cells
|
US8188235B2
(en)
|
2008-06-18 |
2012-05-29 |
Pfizer Inc. |
Antibodies to IL-6 and their uses
|
MX2011000125A
(es)
|
2008-06-30 |
2011-02-25 |
Centocor Ortho Biotech Inc |
Diferenciacion de celulas madre pluripotentes.
|
PL2346988T3
(pl)
|
2008-10-31 |
2017-10-31 |
Janssen Biotech Inc |
Różnicowanie ludzkich zarodkowych komórek macierzystych do linii endokrynnej trzustki
|
MX349178B
(es)
|
2008-10-31 |
2017-07-17 |
Centocor Ortho Biotech Inc |
Diferenciación de células madre embrionarias humanas al linaje endocrino pancreático.
|
CN102245207B
(zh)
*
|
2008-11-13 |
2015-11-25 |
费塔制药股份有限公司 |
人源化抗il-6抗体
|
MX2011005288A
(es)
|
2008-11-20 |
2011-06-01 |
Centocor Ortho Biotech Inc |
Celulas madre pluripotentes en microportadores.
|
CN102257132B
(zh)
|
2008-11-20 |
2014-09-03 |
森托科尔奥索生物科技公司 |
用于在平面基底上进行细胞附着和培养的方法和组合物
|
EP2357166B1
(de)
|
2008-11-20 |
2020-01-15 |
IHI Corporation |
Automagnetische metall-salen-komplexverbindung
|
US8323649B2
(en)
|
2008-11-25 |
2012-12-04 |
Alderbio Holdings Llc |
Antibodies to IL-6 and use thereof
|
US9212223B2
(en)
|
2008-11-25 |
2015-12-15 |
Alderbio Holdings Llc |
Antagonists of IL-6 to prevent or treat thrombosis
|
US8337847B2
(en)
|
2008-11-25 |
2012-12-25 |
Alderbio Holdings Llc |
Methods of treating anemia using anti-IL-6 antibodies
|
US8992920B2
(en)
|
2008-11-25 |
2015-03-31 |
Alderbio Holdings Llc |
Anti-IL-6 antibodies for the treatment of arthritis
|
US8420089B2
(en)
|
2008-11-25 |
2013-04-16 |
Alderbio Holdings Llc |
Antagonists of IL-6 to raise albumin and/or lower CRP
|
US9452227B2
(en)
*
|
2008-11-25 |
2016-09-27 |
Alderbio Holdings Llc |
Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments
|
JP5317690B2
(ja)
|
2008-12-27 |
2013-10-16 |
株式会社東芝 |
メモリシステム
|
WO2011006273A1
(en)
*
|
2009-07-15 |
2011-01-20 |
Eva Kovacs-Benke |
Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases
|
WO2011011300A2
(en)
|
2009-07-20 |
2011-01-27 |
Centocor Ortho Biotech Inc. |
Differentiation of human embryonic stem cells
|
RU2540021C2
(ru)
|
2009-07-20 |
2015-01-27 |
Янссен Байотек, Инк. |
Дифференцировка эмбриональных стволовых клеток человека
|
MX2012000898A
(es)
|
2009-07-20 |
2012-06-01 |
Janssen Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas.
|
KR101436219B1
(ko)
|
2009-10-26 |
2014-09-01 |
에프. 호프만-라 로슈 아게 |
글리코실화된 면역글로불린의 제조 방법
|
WO2011066369A2
(en)
|
2009-11-24 |
2011-06-03 |
Alder Biopharmaceuticals, Inc. |
Antagonists of il-6 to raise albumin and/or lower crp
|
US9775921B2
(en)
|
2009-11-24 |
2017-10-03 |
Alderbio Holdings Llc |
Subcutaneously administrable composition containing anti-IL-6 antibody
|
US9150833B2
(en)
|
2009-12-23 |
2015-10-06 |
Janssen Biotech, Inc. |
Differentiation of human embryonic stem cells
|
JP5882226B2
(ja)
|
2009-12-23 |
2016-03-09 |
ヤンセン バイオテツク,インコーポレーテツド |
ヒト胚性幹細胞の分化
|
JO3417B1
(ar)
|
2010-01-08 |
2019-10-20 |
Regeneron Pharma |
الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
|
JP6013196B2
(ja)
|
2010-03-01 |
2016-10-25 |
ヤンセン バイオテツク,インコーポレーテツド |
多能性幹細胞から誘導した細胞を精製するための方法
|
RU2587634C2
(ru)
|
2010-05-12 |
2016-06-20 |
Янссен Байотек, Инк. |
Дифференцирование эмбриональных стволовых клеток человека
|
ES2932398T3
(es)
|
2010-05-28 |
2023-01-18 |
Chugai Pharmaceutical Co Ltd |
Potenciador de la respuesta de las células T antitumorales
|
MX355340B
(es)
|
2010-08-31 |
2018-04-16 |
Janssen Biotech Inc |
Diferenciación de células madre embrionarias humanas.
|
US9181528B2
(en)
|
2010-08-31 |
2015-11-10 |
Janssen Biotech, Inc. |
Differentiation of pluripotent stem cells
|
EP2853589B1
(de)
|
2010-08-31 |
2017-12-27 |
Janssen Biotech, Inc. |
Differenzierung menschlicher embryonaler Stammzellen
|
EP2787007A3
(de)
|
2010-11-08 |
2015-03-11 |
F. Hoffmann-La Roche AG |
Subkutan verabreichter ANTI-IL-6-Rezeptorantikörper
|
WO2012071561A2
(en)
|
2010-11-23 |
2012-05-31 |
Alder Biopharmaceuticals, Inc. |
Anti-il-6 antibodies for the treatment of anemia
|
AR087305A1
(es)
|
2011-07-28 |
2014-03-12 |
Regeneron Pharma |
Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit
|
TWI589299B
(zh)
|
2011-10-11 |
2017-07-01 |
再生元醫藥公司 |
用於治療類風濕性關節炎之組成物及其使用方法
|
JO3370B1
(ar)
|
2011-11-10 |
2019-03-13 |
Regeneron Pharma |
طريقة لتثبيط نمو الورم عن طريق تثبيط مستقبل انترلوكين 6
|
BR112014015417A8
(pt)
|
2011-12-22 |
2017-07-04 |
Janssen Biotech Inc |
diferenciação de células-tronco embrionárias humanas em células positivas de insulina hormonal únicas
|
SG11201405052RA
(en)
|
2012-03-07 |
2014-10-30 |
Janssen Biotech Inc |
Defined media for expansion and maintenance of pluripotent stem cells
|
DK3450542T3
(da)
|
2012-06-08 |
2021-11-01 |
Janssen Biotech Inc |
Differentiering af humane embryonale stamceller til endokrine pancreatiske celler
|
MX2015008578A
(es)
|
2012-12-31 |
2015-09-07 |
Janssen Biotech Inc |
Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9.
|
US10370644B2
(en)
|
2012-12-31 |
2019-08-06 |
Janssen Biotech, Inc. |
Method for making human pluripotent suspension cultures and cells derived therefrom
|
SG11201505128SA
(en)
|
2012-12-31 |
2015-07-30 |
Janssen Biotech Inc |
Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
|
CN105705634A
(zh)
|
2012-12-31 |
2016-06-22 |
詹森生物科技公司 |
用于分化成胰腺内分泌细胞的人多能细胞的悬浮和群集
|
BR112015032960B1
(pt)
|
2013-07-04 |
2021-01-05 |
F. Hoffmann-La Roche Ag |
imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
|
US9017678B1
(en)
|
2014-07-15 |
2015-04-28 |
Kymab Limited |
Method of treating rheumatoid arthritis using antibody to IL6R
|
CA2949056A1
(en)
|
2014-05-16 |
2015-11-19 |
Janssen Biotech, Inc. |
Use of small molecules to enhance mafa expression in pancreatic endocrine cells
|
CA2995645A1
(en)
|
2015-08-18 |
2017-02-23 |
Regeneron Pharmaceuticals, Inc. |
Anti-pcsk9 inhibitory antibodies for treating patients with hyperlipidemia undergoing lipoprotein apheresis
|
WO2017147169A1
(en)
|
2016-02-22 |
2017-08-31 |
Ohio State Innovation Foundation |
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
|
MA45479A
(fr)
|
2016-04-14 |
2019-02-20 |
Janssen Biotech Inc |
Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
|
WO2018170405A1
(en)
|
2017-03-17 |
2018-09-20 |
Ohio State Innovation Foundation |
Nanoparticles for delivery of chemopreventive agents
|
CN114206442A
(zh)
|
2019-01-31 |
2022-03-18 |
赛诺菲生物技术公司 |
用于治疗幼年特发性关节炎的抗il-6受体抗体
|
EP3947737A2
(de)
|
2019-04-02 |
2022-02-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur vorhersage und vorbeugung von krebs bei patienten mit prämalignen läsionen
|